ERK MAP kinase is targeted to RSK2 by the phosphoprotein PEA-15.
about
Regulation of brain-derived neurotrophic factor exon IV transcription through calcium responsive elements in cortical neuronsIdentification of mitogen-activated protein/extracellular signal-responsive kinase kinase 2 as a novel partner of the scaffolding protein human homolog of disc-largeOn the Quest of Cellular Functions of PEA-15 and the Therapeutic OpportunitiesRSK isoforms in cancer cell invasion and metastasisHow does a protein with dual mitotic spindle and extracellular matrix receptor functions affect tumor susceptibility and progression?PEA15 impairs cell migration and correlates with clinical features predicting good prognosis in neuroblastomaDeletion of PEA-15 in mice is associated with specific impairments of spatial learning abilities.Phosphoprotein enriched in astrocytes 15 kDa (PEA-15) reprograms growth factor signaling by inhibiting threonine phosphorylation of fibroblast receptor substrate 2alpha.The death effector domain protein PEA-15 negatively regulates T-cell receptor signaling.Phosphoprotein enriched in astrocytes (PEA)-15: a potential therapeutic target in multiple disease states.A phospholipase Cγ1-activated pathway regulates transcription in human vascular smooth muscle cells.Characterization of a MAPK scaffolding protein logic gate in gonadotropes.Mitochondrial hexokinase II (HKII) and phosphoprotein enriched in astrocytes (PEA15) form a molecular switch governing cellular fate depending on the metabolic state.PEA-15 potentiates H-Ras-mediated epithelial cell transformation through phospholipase DMEK1/2 inhibitor selumetinib (AZD6244) inhibits growth of ovarian clear cell carcinoma in a PEA-15-dependent manner in a mouse xenograft modelPLD1 participates in BDNF-induced signalling in cortical neuronsPhosphorylation is the switch that turns PEA-15 from tumor suppressor to tumor promoterRegulations of Reversal of Senescence by PKC Isozymes in Response to 12-O-Tetradecanoylphorbol-13-Acetate via Nuclear Translocation of pErk1/2.PEA-15 induces autophagy in human ovarian cancer cells and is associated with prolonged overall survival.Targetting PED/PEA-15 for diabetes treatment.Protein phosphatase 4 regulates apoptosis in leukemic and primary human T-cells.Mechanism of sustained activation of ribosomal S6 kinase (RSK) and ERK by kaposi sarcoma-associated herpesvirus ORF45: multiprotein complexes retain active phosphorylated ERK AND RSK and protect them from dephosphorylation.PED/PEA-15 interacts with the 67 kD laminin receptor and regulates cell adhesion, migration, proliferation and apoptosis.Phospholipase Cϵ Activates Nuclear Factor-κB Signaling by Causing Cytoplasmic Localization of Ribosomal S6 Kinase and Facilitating Its Phosphorylation of Inhibitor κB in Colon Epithelial Cells.R-Ras interacts with filamin a to maintain endothelial barrier function.NMR backbone dynamics studies of human PED/PEA-15 outline protein functional sites.Circadian expression and functional characterization of PEA-15 within the mouse suprachiasmatic nucleus.
P2860
Q24300047-0960359A-C2D6-49F3-8EFB-D744DA00DC3CQ24304418-2A0D87F1-0759-46BA-9EB5-418BD6F02116Q26799216-B90FB60B-8037-4339-B6F2-99C737DE1647Q26827485-8BEECB13-D62D-4B24-8284-BAAC47CDD261Q28240063-4D187685-B832-45FC-B60E-996A9DF9539FQ30417536-9FD93F4B-4F07-436D-AAA7-38DEECC61B1FQ30886844-36EAA9ED-DA55-4198-B194-42F7F5763123Q33647052-E8B61592-0B3C-42D2-BF8B-2A610735546FQ34017062-F8A2E34C-2590-4428-96EB-53E207F55404Q34024181-3B57256C-05C3-4D23-A501-C949EE0FADCCQ34986520-7569EDB2-9BF3-4A7A-906F-4DB5A5C52040Q35001275-EC9798BF-FDB6-478F-A0C1-A479FCBF71EFQ35749617-09076157-5FB9-4FAD-AC42-502D9E12352BQ35809595-6F78C0F9-9D83-46A5-B3C7-F1559EC5A1FEQ35872321-4B8F4599-B884-454B-A8C1-81FF78EAD1DBQ36123489-5993D4A9-7895-46A0-A3D8-3484F5284778Q36235303-6108BD84-9FBC-4100-A309-B839D6CD553BQ36693859-0845B3AF-AE46-46A0-B509-5DD5CC48FFC0Q37178227-C9461FCD-08D7-4646-99B1-7B2BE66F70DFQ39232367-7C1E4801-7DAE-46EE-A6CC-A93876D753B9Q39836083-6F694A65-A8CD-47F4-A572-259C06570AD1Q39869836-2F438BCE-6FF9-45F8-8221-7DE34195B1A0Q41907954-74AD54A3-F043-4AE3-8E2C-2CE5E01A7468Q42051903-603E8D40-EF6F-41D7-9F01-12D350830FCEQ42720353-FBBAA978-794B-43CF-B644-8638A4B39E37Q42913727-F749D0D5-C1C8-48D4-8318-E5E715C2319AQ49565735-E61FD640-E1B4-4913-8FC8-61F18E802340
P2860
ERK MAP kinase is targeted to RSK2 by the phosphoprotein PEA-15.
description
2007 nî lūn-bûn
@nan
2007 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
ERK MAP kinase is targeted to RSK2 by the phosphoprotein PEA-15.
@ast
ERK MAP kinase is targeted to RSK2 by the phosphoprotein PEA-15.
@en
type
label
ERK MAP kinase is targeted to RSK2 by the phosphoprotein PEA-15.
@ast
ERK MAP kinase is targeted to RSK2 by the phosphoprotein PEA-15.
@en
prefLabel
ERK MAP kinase is targeted to RSK2 by the phosphoprotein PEA-15.
@ast
ERK MAP kinase is targeted to RSK2 by the phosphoprotein PEA-15.
@en
P2093
P2860
P356
P1476
ERK MAP kinase is targeted to RSK2 by the phosphoprotein PEA-15.
@en
P2093
Hema Renganathan
Hema Vaidyanathan
John Opoku-Ansah
Michelle L Matter
Sandra Pastorino
P2860
P304
19837-19842
P356
10.1073/PNAS.0704514104
P407
P50
P577
2007-12-06T00:00:00Z